Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SOLUTION: A Pilot Randomised, Double-Blind, Sham-Controlled Clinical Trial Evaluating the Efficacy and Safety of Radial Extracorporeal Shock Wave Therapy as an Adjunct to Botulinum Toxin Type A in Adults With Post-Stroke Lower Limb Spasticity

NCT07875868 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT07875868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07875868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SOLUTION: A Pilot Randomised, Double-Blind, Sham-Controlled Clinical Trial Evaluating the Efficacy and Safety of Radial Extracorporeal Shock Wave Therapy as an Adjunct to Botulinum Toxin Type A in Adults With Post-Stroke Lower Limb Spasticity
Lead sponsor
Parc de Salut Mar
Phase
Phase 1
Overall status
Completed
Start date
February 1, 2024
Completion date
January 1, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower limb spasticity, spasticity as sequela of stroke, stroke, upper motor neuron syndrome